Dominique Maiter
Dominique Maiter
Although the diagnosis of prolactinoma is often straightforward and the treatment strategy has been well defined in recent guidelines, several challenging issues persist in their management. The differential diagnosis of a large pituitary t...
Isabel Huguet,Georgia Ntali,Ashley Grossman et al.
Isabel Huguet et al.
Cushing's disease (CD) is a rare disorder caused by an adrenocorticotropic hormone (ACTH)-secreting pituitary adenoma. Chronic exposure to hypercortisolism leads to significant morbidities, which may be only partially reversible after remis...
Alper Sonmez
Alper Sonmez
Dyslipidemia is the major risk factor for atherosclerotic cardiovascular diseases. A multitude of lipid guidelines exist, with several controversies, and the best approach in dyslipidemia management is not clear. The tools and lipoproteins ...
Peter M Nilsson
Peter M Nilsson
Cardiovascular disease (CVD) is a prevalent condition in the elderly, often associated with metabolic disturbance and type 2 diabetes. For a number of years, research dedicated to understand atherosclerosis dominated, and for many good reas...
GLP-1 Receptor Agonists in Type 2 Diabetes and Beyond - New Insights 2015 [0.03%]
2015年GLP-1受体激动剂与2型糖尿病及其他疾病的新认识
Baptist Gallwitz
Baptist Gallwitz
Glucagon-like peptide-1 receptor agonists (GLP-1 RAs) were introduced for type 2 diabetes therapy nearly 10 years ago, among them short-acting compounds on the basis of the GLP-1-like peptide exendin-4 (exenatide and lixisenatide) and a lon...
Insulin Glulisine in Pregnancy - Experience from Clinical Trials and Post-marketing Surveillance [0.03%]
格鲁利西 insulin 在妊娠期的经验：临床试验和上市后监测结果
Zoran Doder,Demi Vanechanos,Manfred Oster et al.
Zoran Doder et al.
Pregnancies complicated by gestational diabetes or pre-existing type 1 or type 2 diabetes mellitus are associated with a higher rate of adverse outcomes compared with pregnancies in the background population. These outcomes include miscarri...
Equivalent Recombinant Human Insulin Preparations and their Place in Therapy [0.03%]
重组人胰岛素类似制剂及其治疗意义
Juergen Sandow,Wolfgang Landgraf,Reinhard Becker et al.
Juergen Sandow et al.
Recombinant human insulin was one of the first products of biotechnology. It was developed in response to the need for a consistent and sufficient worldwide supply. Recombinant human insulin replaced the animal insulins and semisynthetic in...